Defective Medicare Bidding Program For Medical Equipment Forces Severe Hardships On California Business Owners And Beneficiaries
LOS ANGELES, April 2, 2013 /PRNewswire-USNewswire/ -- The controversial Medicare bidding procurement program for home medical equipment is forcing many small and large providers in California to lay off employees or close their businesses, developments that will likely disrupt the quality of service and products received by Medicare beneficiaries, says AAHomecare.
Under the defective and dangerous program, the Centers for Medicare & Medicaid Services (CMS) is reducing reimbursements to providers an average of 45 percent when the bidding program expands to 91 new locations in July. Due to these arbitrary cuts, many providers say they can no longer supply Medicare patients with durable medical equipment (DME), which includes critical medical devices such as power wheelchairs, hospital beds, oxygen, and diabetic supplies. Some of their stories are heartbreaking.
"Medicare has completely mismanaged the design and implementation of this bidding program," said Tyler Wilson, president of the American Association for Homecare (AAHomecare). "It is creating havoc for providers in California and across the country. And it is jeopardizing the health of some of the most vulnerable people in our society. It is time Congress and the Administration end this bad experiment and create a program that guarantees quality service, while offering businesses fair, market pricing."
Wilson called the current program "a sham." CMS basically imposes a contract price anywhere between the lowest and highest bids that are made by providers. But at the same time, all the bids are non-binding, which has led some suppliers to make desperate "suicide" low bids in an effort to win contracts in enough equipment categories to stay in business.What destroys the integrity of the process is that even these ridiculously low bids are utilized by CMS to establish their unrealistic prices. "The entire process lacks transparency because CMS never discloses how these unrealistic prices are calculated," Wilson said. "This is government imposed pricing, not competitive bidding, and it is eliminating competition rather than increasing it."
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts